SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Niclós G, Olivar T, Rodilla V. Int. J. Pharm. Pract. 2018; 26(3): 242-249.

Affiliation

Department of Pharmacy, Universidad CEU Cardenal Herrera, Moncada, Valencia, Spain.

Copyright

(Copyright © 2018, Royal Pharmaceutical Society of Great Britain, Publisher John Wiley and Sons)

DOI

10.1111/ijpp.12386

PMID

28795462

Abstract

OBJECTIVE: To investigate the association between polypharmacy and sociodemographic factors as well as health status, determinants of health and healthcare use, illness and use of prescribed medicines amongst adults in Spain.

METHODS: Data from the 2009 European Health Interview Survey in Spain which included 22 188 subjects were used. Polypharmacy was defined as the use of five or more prescribed medicines. The association between polypharmacy and several variables was assessed by means of bivariate analysis and logistic regression analysis (adjusted by age and gender). KEY FINDINGS: Amongst study participants, 15.8% were on prescribed polypharmacy (19.3%, women; 10.3%, men (P < 0.001)). A number of sociodemographic factors (e.g. age, gender, educational level), health status factors (e.g. limitation in daily activities, self-perception of health, presence of chronic disease) and other health-related factors (e.g. smoking, alcohol drinking, physical activity) have been studied and have been found to play a role in polypharmacy. Logistic regression analysis provided three variables which together with age could be used to predict polypharmacy.

CONCLUSION: In Spain, approximately 16% of people who take medicines are on polypharmacy and this is more frequent in women and amongst older adults. From our study, we can conclude that the variables which can predict a higher likelihood of polypharmacy are, together with age, prescribed antidepressants, and prescribed medicines for back/neck pain and joint pain. This may provide a tool for health professionals to readily assess polypharmacy appropriateness in polymedicated patients.

© 2017 Royal Pharmaceutical Society.


Language: en

Keywords

Cross-sectional studies; European Health Survey; Multiple medication use; Polypharmacy; Spain

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print